NYSE | TSX: ACB
EDMONTON, AB, Sept. 28, 2020 /CNW/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian
company defining the future of cannabinoids worldwide, announced
today that it plans to file its Management Information Circular
(the "Information Circular") and related proxy materials on SEDAR
and EDGAR on September 29, 2020 in
relation to the upcoming Annual General and Special Meeting (the
"AGM") to be held on Thursday, November 12,
2020 at 10:00 AM (Mountain
Time). The Company has elected to use the notice and access
procedure, with mailing expected to follow in the coming days.
Due to the global COVID-19 public health emergency, the AGM will
be held for the first time in a virtual-only format, via live
webcast at https://web.lumiagm.com/242822694. A virtual-only
meeting is being adopted this year to give all shareholders an
equal opportunity to participate at the meeting regardless of their
geographic location or particular constraints, circumstances or
risks they may be facing as a result of COVID-19. Further details,
including business to be conducted at the meeting and instructions
on how to vote and attend the virtual meeting, can be found in the
Information Circular and related proxy material.
Additionally, 280 Park ACI Holdings LLC has resigned as senior
advisor to the Company, effective September
25, 2020 in order to pursue other commitments. 280 Park ACI
Holdings LLC, the principal of which is Nelson Peltz, had been providing services to the
Company since March 2019 with respect
to its US strategic initiatives.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and Reliva. Providing customers with innovative, high-quality
cannabis and hemp products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These forward-looking statements are only
predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions, estimates and
assumptions of management in light of management's experience and
perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current
and future market conditions, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including general business and economic
conditions, changes in laws and regulations, product demand,
changes in prices of required commodities, competition, the effects
of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 24, 2020 (the "AIF") and filed with
Canadian securities regulators available on the Company's issuer
profile on SEDAR at www.sedar.com. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
laws.
SOURCE Aurora Cannabis Inc.